https://orcid.org/0000-0002-2678-8989
References
- Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol. 2013;122(5):1122–1131.
- Carty DM, Delles C, Dominiczak AF. Preeclampsia and future maternal health. J Hypertens. 2010;28(7):1349–1355.
- Lyall F. Mechanisms regulating cytotrophoblast invasion in normal pregnancy and pre-eclampsia. Aust N Z J Obstet Gynaecol. 2006;46(4):266–273.
- Farina A, Hasegawa J, Raffaelli S, et al. The association between preeclampsia and placental disruption induced by chorionic villous sampling. Prenat Diagn, 6. 2010;30:571–574.
- Moffett A, Hiby SE. How does the maternal immune system contribute to the development of pre-eclampsia? Placenta. 2007;28:S51–S56.
- Silver RK, Wilson RD, Philip J, et al , Late first-trimester placental disruption and subsequent gestational hypertension/preeclampsia. Obstet Gynecol. 2005;105(3):587–592.
- Odibo AO, Singla A, Gray DL, et al. Is chorionic villus sampling associated with hypertensive disorders of pregnancy? Prenat Diagn. 2010;30:9–13.
- Adusumalli J, Han CS, Beckham S, et al. Chorionic villus sampling and risk for hypertensive disorders of pregnancy. Am J Obstet Gynecol, 6. 2007;196:591.e1–e7; discussion 591.e7.
- Tranquilli AL, Brown MA, Zeeman GG, et al. The definition of severe and early-onset preeclampsia. Statements from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Pregnancy Hypertens. 2013;3(1):44–47.
- Wilson ML, Goodwin TM, Pan VL, et al. Molecular epidemiology of preeclampsia. Obstet Gynecol Surv. 2003;58:39–66.
- Daskalakis G, Papapanagiotou A, Antonakopoulos N, et al. Invasive diagnostic procedures and risk of hypertensive disorders in pregnancy. Int J Gynaecol Obstet. 2014;125(2):146–149.
- Grobman WA, Auger M, Shulman LP, et al. The association between chorionic villus sampling and preeclampsia. Prenat Diagn. 2009;29(8):800–803.
- Lindgren P, Cederholm M, Haglund B, et al. Invasive procedures for fetal karyotyping: no cause of subsequent gestational hypertension or pre-eclampsia. BJOG, 2010;117:1422–1425.
- Khalil A, Akolekar R, Pandya P, et al. Chorionic villus sampling at 11 to 13 weeks of gestation and hypertensive disorders in pregnancy. Obstet Gynecol. 2010;116(2 Pt 1):374–380.
- Cederholm M, Haglund B, Axelsson O. Maternal complications following amniocentesis and chorionic villus sampling for prenatal karyotyping. BJOG, 4. 2003;110:392–399.
- Maruotti GM, Giudicepietro A, Saccone G, et al. Risk of preeclampsia in of women who underwent chorionic villus sampling. J Matern Fetal Neonatal Med. 2019;32(18):3012–3015.
- Gezer C, Ekin A, Goynumer G, et al. Comparison of adverse perinatal outcomes after single-needle and double-needle CVS techniques. J Perinat Med 2017;45(2):199–203.